AzTrials
AzTrials

One-lung VentilationPhase 4NCT01073722

EZ Blocker Versus Left Sided Double-lumen Tube

A Phase 4 study testing Placement of double lumen tube for one-lung ventilation and Placement of EZ- Blocker for one-lung ventilation in people with One-lung Ventilation, run by Radboud University Medical Center at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Lung isolation is used to achieve one lung ventilation to facilitate thoracic surgery. Two methods are commonly used, a double lumen tube (DLT) or a bronchial blocker introduced through a single lumen tube. However, both techniques have advantages and disadvantages. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
One-lung Ventilation
What is being tested?
Placement of double lumen tube for one-lung ventilation and Placement of EZ- Blocker for one-lung ventilation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteNetherlands
Study dates
Feb 2010to Apr 2011
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ASA physical status 1-3 patients
  • Patients scheduled for surgery requiring a left sided DLT for single lung ventilation

Who cannot join

  • Contraindications are lesions along the path of the left sided double lumen tube or the EZB
  • Tracheal or mainstem bronchial stenosis
  • Distorted carinal anatomy,
  • Anticipated difficult intubation (Mallampatti score ≥ 3)
  • History or presence of tracheostoma
  • Patients who require absolute lung separation
  • Patients who require sleeve resection of mainstem bronchus

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Department of Anesthesiology, Pain and Palliative Medicine of the Radboud University Nijmegen Medical Centre

    Nijmegen, Gelderland, 6500HB

Other trials in Netherlands

About this study

Official title: Endobronchial EZ Blocker Compared to Left Sided Double-lumen Tube for One-lung Ventilation

Lung isolation is used to achieve one lung ventilation to facilitate thoracic surgery. Two methods are commonly used, a double lumen tube (DLT) or a bronchial blocker introduced through a single lumen tube. However, both techniques have advantages and disadvantages. Briefly, the DLT can be positioned faster and remains firmly in place, but is sometimes difficult or even impossible to introduce. The DLT is larger than a conventional single lumen tube and the incidence of postoperative hoarseness and airway injuries is higher. Compared to the DLT, bronchial blocking devices are more difficult to position and need more frequent intraoperative repositioning. These disadvantages of the existing devices for lung isolation prompted further development of the bronchial blocker concept. The design of a new Y shaped bronchial blocker, the EZ- Blocker® (AnaesthetIQ BV, Rotterdam, The Netherlands) (EZB), combines the advantages of both lung isolation techniques. The aim of the study is to compare in a randomised, prospective way the ease of placement, the incidence of malpositioning and the quality of lung deflation of a left DLT and a EZB. Secondly, the incidence and severity of damage to laryngeal, tracheal and bronchial structures caused by the use of the DLT or the EZB is a target of the study.

Being tested
Placement of double lumen tube for one-lung ventilation, Placement of EZ- Blocker for one-lung ventilation
Keywords
thoracic surgery, one-lung ventilation, double lumen tube, endobronchial blocker

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Placement of double lumen tube for one-lung ventilationDevice

    Also called Broncho-cath (Mallinckrodt)

    The gold standard for lung isolation is the use of a double lumen tube (DLT). A DLT is a bifurcated tube with a bronchial and a tracheal lumen.

  • Placement of EZ- Blocker for one-lung ventilationDevice

    Also called EZ-blocker (AnaesthetIQ BV, Rotterdam, The Netherlands)

    Bronchial blockers are balloon-tipped semi-rigid catheters. Different types are available. They are not easy to put in position and frequently dislocates during repositioning of the patient or during surgical manipulation. To solve these problems, a novel type of bronchus blocker, i.e. the EZ- Blocker® is developed. The EZB is also a semi-rigid catheter but it has two distal extensions, both with an inflatable cuff and a central lumen. These improvements owe to the fact that the blocker anchors itself on the carina with the two extensions.

Study groups in NCT01073722
Study groupRoleWhat they receive
Left double lumen tubeActive comparatorTraditionally, single lung ventilation is obtained with a double lumen tube (DLT). In our institution a polyvinyl DLT (Broncho-cath, Mallinckrodt,) without carinal hook, is used. This type of tube exists of a tube with two lumen with two distal cuffs. One lumen (called the bronchial lumen) extends some distance further, has a slight curvature and has a small blue cuff. The other lumen (called the tracheal lumen) has a larger cuff. A DLT tube exists in four sizes and one can choose in a left or a right configuration. Almost always, we use a left sided DLT. A DLT has a much larger diameter than a standard single lumen endotracheal tube
Receives: Device: Placement of double lumen tube for one-lung ventilation
EZ-blockerActive comparatorThe EZ-blocker (EZB) is a semi-rigid catheter but it has two distal extensions, both with an inflatable cuff and a central lumen. It is intended for use in combination with a standard single lumen tube. After the EZB is advanced trough the distal end of the single lumen tube, both extensions spread out and find their way in the left and right main stem bronchi. The place where the two extensions are attached to the shaft now rests on the carina. Fiber optic bronchoscopy should be used for proper positioning. After placement of the EZB, one of the cuffs can be inflated to obtain lung separation under direct visual inspection with fiber optic bronchoscopy.
Receives: Device: Placement of EZ- Blocker for one-lung ventilation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the incidence of malposition of a left sided DLT or the EZB

    Measured: there are four time points (after insertion of the device, after inflation of cuff or balloon, after repositioning patient, during surgery) were malposition are considered. Total time spend is 3 hours on the day of the operation

Secondary outcomes (3)
  1. description of damage to laryngeal, tracheal and bronchial structures

    Measured: videobronchoscopy before and after intervention. Time frame 5 min for each video and additional 5 min for assessment afterwards on the day of the operation

  2. the ease of insertion

    Measured: the ease of insertion of the devices is qualitative variable: 1= excellent, 2= good, 3=average, 4=poor. Time frame is 5 min on the day of the operation.

  3. the incidence of postoperative complains of sore throat and hoarseness

    Measured: questionnaire (2 questions, time frame is 1 min) after surgery and one day after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Feb 2010 (estimated)
  2. Study startFeb 2010
  3. Primary completionApr 2011
  4. Study completionApr 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Care provider
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01073722
Sponsor's protocol ID
NL30799,091,09
Status last verified
Aug 2010
First submitted
17 Feb 2010
Last updated
2 May 2011
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Placement of double lumen tube for one-lung ventilation and Placement of EZ- Blocker for one-lung ventilation in people with One-lung Ventilation, run by Radboud University Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 May 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the incidence of malposition of a left sided DLT or the EZB (time frame: there are four time points (after insertion of the device, after inflation of cuff or balloon, after repositioning patient, during surgery) were malposition are considered. Total time spend is 3 hours on the day of the operation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 May 2011; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in